linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company News  
Biocon Ltd.
 
BSE Code 532523
ISIN Demat INE376G01013
Book Value 167.07
NSE Code BIOCON
Dividend Yield % 0.12
Market Cap 686292.35
P/E 1844.87
EPS 0.23
Face Value 5  
24-Jun-2026 Biocon informs about press release
11-Jun-2026 Biocon acquires stake in Ampin C&I Power Twelve
11-Jun-2026 Biocon inches up on acquiring stake in Ampin C&I ...
01-Jun-2026 Biocon informs about investor presentation
11-May-2026 Biocon’s arm gets nod from Health Canada for Mica...
11-May-2026 Biocon informs about company statement
11-May-2026 Biocon surges as its arm gets nod from Health Can...
08-May-2026 Biocon reports 63% fall in Q4 consolidated net pr...
08-May-2026 Biocon declines on reporting 63% fall in Q4 conso...
08-May-2026 Biocon informs about earnings call
08-May-2026 Biocon informs about monitoring agency reports
06-May-2026 Clarification sought from Biocon Ltd
30-Apr-2026 USFDA completes Pre-License inspection at Biocon’...
30-Apr-2026 Biocon informs about company statement
21-Apr-2026 Biocon’s Bosaya, Vevzuo get NoC from Health Canada
Page 1 of 7
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.